-
Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic.
Division of Cardiovascular and Pulmonary Research, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania, 19406, USA.
PMID: 10373396 [PubMed - indexed for MEDLINE]
-
Cited by 13 PubMed Central articles